Von Minckwitz G, Procter MJ, De Azambuja E

[1] Von Minckwitz G, Procter MJ, De Azambuja E, Zardavas D, Knott A, Viale G, et al. APHINITY trial (BIG 4-11): A randomized comparison of chemotherapy (C) plus trastuzumab (T) plus placebo (Pla) versus chemotherapy plus trastuzumab (T) plus pertuzumab (P) as adjuvant therapy in patients (pts) with HER2-positive early breast cancer (EBC). J Clin Oncol 35, 2017 (suppl; abstr LBA500)
[2] Cancer Facts & Figures 2015. American cancer Society. Atlanta: American Cancer Society; 2015.